We are live on ! Find out more
FLNA icon

Filana Therapeutics

100 hedge funds and large institutions have $22.3M invested in Filana Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 33 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more call options, than puts

Call options by funds: $2.27M | Put options by funds: $1.29M

7.39% less ownership

Funds ownership: 32.86% → 25.47% (-7.4%)

17% less funds holding

Funds holding: 120 → 100 (-20)

24% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 33

53% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 38

69% less capital inflows, than outflows

Capital inflows: $3.61M | Capital outflows: $11.6M

Holders
100
Holders Change
-20
Holders Change %
-16.67%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
33
Closed
38
Calls
$2.27​M
Puts
$1.29​M
Net Calls
+$986​K
Net Calls Change
-⁠$372​K

FLNA Hedge Fund Activity: Q2 2025 in Review

100 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2025, worth a combined $22.3M — down 13% from $25.7M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of FLNA and 18 opened new positions — a net loss of 20 holders — while 33 trimmed existing stakes and 25 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $841K. The largest seller was BlackRock, cutting an estimated $3.43M.

  • 100 institutional investors held Filana Therapeutics (FLNA) as of Q2 2025, down from 120 in Q1 2025.
  • Funds reported $22.3M of Filana Therapeutics stock for Q2 2025, down 13% quarter-over-quarter.
  • 18 funds opened new Filana Therapeutics positions in Q2 2025 and 38 closed out, a net change of -20 holders.
  • The largest Filana Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $841K added.
  • The largest Filana Therapeutics seller in Q2 2025 was BlackRock, an estimated $3.43M sold.

Based on aggregated 13F filings for Q2 2025.